FDA Approves Abbisko's PIMJETMI For Tenosynovial Giant Cell Tumor

(RTTNews) - On Wednesday, Abbisko Medicine Co., Ltd. (2256.HK) announced that the U.S. Food and Drug Administration, or FDA approved PIMJETMI as a systemic treatment for adults with symptomatic tenosynovial giant cell tumor for whom surgery may worsen functional limitations or ca